Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.28p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 212,860
  • Market Cap: £5.91m

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

Notice of Results and Ox-1 presentation 23-May-2025 07:14 RNS
Holding(s) in Company 22-May-2025 12:43 RNS
Director/PDMR Shareholding 22-May-2025 12:22 RNS
Holding(s) in Company 16-May-2025 13:00 RNS
Master Service Agreement signed for Ox-1 programme 12-May-2025 07:00 RNS
Board Appointment, Grant of Options, PDMR Dealing 01-May-2025 07:00 RNS
Holding(s) in Company 21-Mar-2025 15:55 RNS
Holding(s) in Company 20-Mar-2025 15:33 RNS
Holding(s) in Company 20-Mar-2025 11:01 RNS
Holding(s) in Company 19-Mar-2025 12:10 RNS
Holding(s) in Company 17-Mar-2025 14:17 RNS
Holding(s) in Company 17-Mar-2025 07:00 RNS
Holding(s) in Company 17-Mar-2025 07:00 RNS
Holding(s) in Company 17-Mar-2025 07:00 RNS
Holding(s) in Company 13-Mar-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.28p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 212,860
Shares Issued 2,148.96m
Market Cap £5.91m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.02% below the market average46.02% below the market average46.02% below the market average46.02% below the market average46.02% below the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Price Trend
92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average
Income Not Available
Growth
15.76% below the market average15.76% below the market average15.76% below the market average15.76% below the market average15.76% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average

Theracryf Dividends

No dividends found

Trades for 02-Jun-2025

Time Volume / Share Price
08:29 212,860 @ 0.25p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page